UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 19, 2022

Accession Number:	0001213900-22-019866
Submission Type:	POS AM
CIK: 0001601936 Company Name: Altamira Therapeutics Ltd. File Number: 333-262592